SCHEMBL8317987

SCHEMBL8317987

CC(C)N1Cc2cccc(Cl)c2N(CCCl)S1(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.36
CYP2D6 P10635 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
NOTUM Q6P988 1/20 0.35
HSD17B3 P37058 1/20 0.34
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
DRD3 P35462 3/20 0.33
KCNH2 Q12809 2/20 0.33
DRD2 P14416 2/20 0.32
ACACB O00763 1/20 0.32
USP2 O75604 1/20 0.32
RORC P51449 1/20 0.31
ALDH1A1 P00352 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8315238 0.88 P2RX7 (0.33) KDM4EPKML3MBTL1DRD2AADAT
SCHEMBL8318169 0.86 SLC6A2 (0.34) DRD3KCNH2ALDH1A1MC4R
SCHEMBL8315724 0.83 P2RX7 (0.35) KDM4EDRD3KCNH2ACACBALDH1A1
SCHEMBL8318057 0.82 KDM4E (0.39) KDM4EPKML3MBTL1RORC
SCHEMBL8317165 0.74 SLC6A2 (0.39) KDM4EPKML3MBTL1DRD2RORC
SCHEMBL8314015 0.74 SLC6A2 (0.39) NOTUMKDM4EPKML3MBTL1DRD3
SCHEMBL8316061 0.74 CRY1 (0.35) KCNH2
SCHEMBL8316696 0.73 SLC6A2 (0.38) KDM4EPKML3MBTL1DRD2RORC
SCHEMBL6985168 0.72 HTR2A (0.40) KDM4EPKML3MBTL1
SCHEMBL6982495 0.71 KCNH2 (0.32) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929072-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ELI LILLY AND COMPANY LIMITED (GB) 1999-07-27 US disclosed
EP-0897921-A1 Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands ELI LILLY AND COMPANY LIMITED (GB) 1999-02-24 EP disclosed